By Nens van Alfen, MD, PhD
Current immunomodulatory treatments for MS are not reliable to prevent long-term disability, but future agents focusing on remyelination and axonal and neuronal repair could reverse this course.
By Martina Novotna, MD, Moses Rodriguez, MD, and Orhun H. Kantarci, MD
With Ruth Ann Marrie, MD, PhD
The first installment of a two-part series exploring the impact of recreational and medical marijuana on cognitive function and neurological disorders.
By Ronald Devere, MD, FAAN
Clinicians should consider a diagnosis of West Nile Virus in patients with acute flaccid paralysis, particularly those who come from areas where WNV is endemic.